Inulin Supplementation in Patients With Type 1 Diabetes
NCT ID: NCT05795972
Last Updated: 2023-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2020-06-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, the primary objective of the study is represented by the proportion of patients with better glycemic control (basal and post-prandial euglycemia time) and optimal metabolic control (HbA1c, lipid profile, C-RP).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Inulin Supplementation on Glycaemic Control and Immunological Parameters in Type 1 Diabetes (2024)
NCT07050888
Prebiotics in Patients With Type 1 Diabetes
NCT04963777
D-chiro-Inositol in Overweight Type 1 Diabetes Patients
NCT02730949
Prebiotic Fiber Supplement in T1DM Children
NCT02442544
Supplementation of Inulin + L. Acidophilus in Elders with T2DM
NCT06830824
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inulin supplementation
inulin
patients treated with standard therapy with a supplementation of Inulin 6g twice a day for 3 months.
standard therapy
standard therapy
control group (patients treated also with standard therapy)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inulin
patients treated with standard therapy with a supplementation of Inulin 6g twice a day for 3 months.
standard therapy
control group (patients treated also with standard therapy)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* BMI\> 30 kg / m2.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
OJETTI VERONICA
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3099
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.